Safe S.A. specializes in the design, manufacture and marketing of medical devices for spine surgery. The company offers implants and instruments in the range of SteriSpine (the first spinal arthrodesis system that is for single use and is sterile and totally traceable). The group's activity is organized around 2 areas: - direct and indirect sales of medical devices (Safe Orthopaedics): business carried out in France, Germany, the United Kingdom, the United States and South America; - subcontracted manufacturing services for orthopedic medical devices (Safe Medical).

Employees

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement and Estimates

More financial data

End-of-day quote Euronext Paris Other stock markets 08/07/2025			5-day change	1st Jan Change
2.400 ^EUR	-.--%		-.--%	-96.67%

06-30	Safe Group sharply improves its full-year results
06-29	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI

Market Cap	128K 146K 118K 108K 204K 14.05M 209K 1.41M 553K 6.88M 548K 536K 23.69M	P/E 2024 *	-	P/E 2025	-0.07x
Enterprise Value	13.24M 15.14M 12.22M 11.26M 21.23M 1.46B 21.68M 146M 57.39M 714M 56.86M 55.61M 2.46B	EV / Sales 2024	2.39x	EV / Sales 2025	2.47x
Free-Float	87.27%	Yield 2024 *	-	Yield 2025	-

06-30	Safe Group sharply improves its full-year results
06-29	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2025	CI
05-28	Safe And ABL Alpstein Sign Exclusive Distribution Agreement For SteriSpine Range In Peru	CI
05-28	Safe Group enters Peru with exclusive distribution agreement
03-16	Changes to the SAFE Board of Directors
12-17	Safe Orthopaedics Signs Exclusive Distribution Agreement for Spanish Market	MT
12-17	Safe Group Signs Strategic Distribution Agreement in Spain with Vortrom Biologics	CI
12-01	Safe Orthopaedics SA Reports Earnings Results for the Full Year Ended December 31, 2024	CI
28/07/25	Alert wrongly tagged to Safe SA withdrawn	RE
27/12/24	Safe Orthopaedics SA Reports Earnings Results for the Half Year Ended June 30, 2024	CI
09/09/24	The market burns its idols
05/02/24	Safe: wins its appeal against Neo Medical
28/12/23	Safe: audit initiated for a turnaround plan

12-22	SAFE, SPONSOR OF THE 12TH MAMMI INTERNATIONAL CONFERENCE IN ITALY	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	GL
12-17	SAFE SIGNS A STRATEGIC DISTRIBUTION AGREEMENT IN SPAIN WITH VORTROM BIOLOGICS	AQ
09/09/24	New bond financing agreement in a minimum amount of €3 million in anticipation of validation of the continuation plan	GL
24/11/23	Safe group announces the convocation of the Annual General Meeting of Shareholders to be held on December 15th 2023 and provides an update on the situation	AQ

Safe Orthopaedics SA Stock Euronext Paris

Stocks

ALSAF

FR001400RKU0

Medical Equipment, Supplies & Distribution

Valuation: Safe Orthopaedics SA

Latest news : Safe Orthopaedics SA

Press Releases: Safe Orthopaedics SA

News in other languages: Safe Orthopaedics SA

Managers and Directors: Safe Orthopaedics SA

Medical Devices & Implants

Financials

Company Profile

Income Statement and Estimates

06-30	Safe Group améliore nettement ses résultats annuels
05-28	Safe Group s'implante au Pérou avec un accord de distribution exclusif
04-28	Safe S A : Report de la publication des résultats annuels 2025 de SAFE Group
03-31	SAFE - Forte dynamique de développement au Venezuela
03-16	Evolutions au sein du Conseil d'Administration de SAFE

Manager	Title	Age	Since
Nicolas Papillon CEO	Chief Executive Officer	46	-
Thomas Droulout CTO	Chief Tech/Sci/R&D Officer	50	15/02/2010
François-Henri Reynaud DFI	Director of Finance/CFO	-	09/11/2017

Director	Title	Age	Since
Thomas Droulout BRD	Director/Board Member	50	-
François-Henri Reynaud BRD	Director/Board Member	-	26/11/2019
Ismaël Nujurally BRD	Director/Board Member	69	26/11/2019

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SAFE ORTHOPAEDICS SA	-.--%	-.--%	-	-	146K
STRYKER CORPORATION	-3.42%	-2.21%	-18.16%	+5.77%	127B
SMITH & NEPHEW PLC	-1.03%	+1.81%	+4.97%	-2.46%	13.2B
GLAUKOS CORPORATION	+0.93%	+1.13%	+59.22%	+98.29%	9.12B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+3.09%	+17.07%	-42.37%	-68.89%	4.34B
DOUBLE MEDICAL TECHNOLOGY INC.	-6.27%	-0.60%	+8.73%	+42.86%	2.88B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-6.41%	-6.79%	-22.60%	-31.76%	1.73B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-4.80%	+0.06%	-7.58%	-23.28%	1.68B
ENOVIS CORPORATION	-3.56%	+7.34%	-11.36%	-58.51%	1.62B
Average	-2.39%	+3.80%	-3.65%	-4.75%	20.19B
Weighted average by Cap.	-2.90%	+1.85%	-11.94%	+7.63%

	2024	2025
Net sales	5.04M 5.77M 4.65M 4.29M 8.08M 555M 8.26M 55.63M 21.85M 272M 21.65M 21.17M 936M	5.36M 6.13M 4.95M 4.56M 8.6M 591M 8.79M 59.19M 23.25M 289M 23.04M 22.53M 996M
Net income	-1.93B -2.21B -1.78B -1.64B -3.09B -213B -3.16B -21.29B -8.36B -104B -8.29B -8.1B -358B	-4.67M -5.35M -4.31M -3.97M -7.49M -515M -7.66M -51.58M -20.26M -252M -20.07M -19.63M -868M
Net Debt	11.47M 13.12M 10.59M 9.75M 18.39M 1.26B 18.79M 127M 49.72M 619M 49.27M 48.18M 2.13B	13.11M 15M 12.1M 11.15M 21.02M 1.44B 21.47M 145M 56.84M 707M 56.32M 55.08M 2.44B